Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. PPD, Inc.
  6. News
  7. Summary
    PPD   US69355F1021

PPD, INC.

(PPD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

PPD : Q2 Results Increase from Year Ago

07/28/2021 | 05:29pm EDT


ę MT Newswires 2021
All news about PPD, INC.
09/21PPD : Earns Gold Award for Excellence in Employee Learning and Development
BU
09/09FIELD TRIP HEALTH : To Pursue Treatment Resistant Depression and Postpartum Depression as ..
MT
09/01PPD : Receives Award Recognizing Employee Talent Development
BU
08/09THERMO FISHER SCIENTIFIC : Plans Senior Notes Offering
MT
08/05Biden's antitrust crackdown adds to anxiety of merger investors
RE
07/29PPD : Management's Discussion and Analysis of Financial Condition and Results of Operation..
AQ
07/28PPD : Q2 Results Increase from Year Ago
MT
07/28PPD : Reports Second Quarter and Year-To-Date 2021 Results (Form 8-K)
PU
07/28PPD : Earnings Flash (PPD) PPD Posts Q2 Revenue $1.58B
MT
07/28PPD : Earnings Flash (PPD) PPD Posts Q2 EPS $0.39
MT
More news
Analyst Recommendations on PPD, INC.
More recommendations
Financials (USD)
Sales 2021 5 674 M - -
Net income 2021 329 M - -
Net Debt 2021 3 105 M - -
P/E ratio 2021 50,2x
Yield 2021 0,02%
Capitalization 16 442 M 16 442 M -
EV / Sales 2021 3,44x
EV / Sales 2022 3,13x
Nbr of Employees 26 000
Free-Float 61,5%
Chart PPD, INC.
Duration : Period :
PPD, Inc. Technical Analysis Chart | PPD | US69355F1021 | MarketScreener
Technical analysis trends PPD, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Last Close Price 46,80 $
Average target price 47,55 $
Spread / Average Target 1,60%
EPS Revisions
Managers and Directors
David S. Simmons Chairman & Chief Executive Officer
Christopher G. Scully CFO, Treasurer, Executive VP & Assistant Secretary
David Johnston Executive VP-Global Clinical Development
Karen Kaucic Chief Medical Officer & Executive Vice President
Rob Petrie Chief Technology Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
PPD, INC.36.76%16 442
MODERNA, INC.321.86%177 895
LONZA GROUP AG33.16%61 006
IQVIA HOLDINGS INC.44.97%49 771
CELLTRION, INC.-23.26%31 824
SEAGEN INC.-3.41%30 776